News
Nobel İlaç's Rise in the Companies Ranking Continues
Nobel İlaç, which continued its rise to 239th place in the "ISO-Turkey's 500 Largest Industrial Enterprises" survey, rose 20 places to 296th place in the "Fortune 500" survey, which determines Turke...
Our virus-like particles (VLP) vaccine is in Phase II stage
COVIBEL, the innovative local Corona Virus vaccine, which is on the vaccine candidate list of the World Health Organization, produced at the biotechnological pharmaceutical raw material facil...
Nobel İlaç was among the top three pharmaceutical companies in R&D investment
The results of the research of Turkey's 250 companies with the highest R&D expenditures have been announced.
Nobel İlaç won the second prize in the “IKMIB (Istanbul Chemicals and Chemical Products Exporters Association) 2020 Stars of Exports Awards, Pharmaceutical Products” category
The export stars of 2020 were determined in the chemical industry, which mak...
Be Understanding Our WEB Site Opened
Prevention starts with understanding! "Halden Anlamak (Be Understanding)" is a social responsibility project that is realized with the unconditional contributions of Nobel İlaç and supports the communication betwee...
We Won Our 3rd Prize with Our Smiling Masks Project
At the PRIDA Communication Awards organized by the Communication Consultancy Companies Association (IDA), we were awarded 1st place in the Digital and Social Media Communication, User Generated Conte...
We took part in The New York Times with our vaccination study
We proudly share with you our work that creates value for health.
We Are Together For Rare Diseases
We said "We are together for rare diseases” and talked about Rare diseases in Instagram live stream moderated by Derya Baykal.
Our Pharma Commercial Group Director, Karin Soydan, was listed among Turkey's 50 Most Influential CMOs
We are proud to announce that Nobel Medicine Pharma Commercial Group Director Karin Soydan was listed among Turkey's most influential 50 CMOs in Tur...
Studies for Domestic Vaccine Are Continued Without Slowing Down at Nobel İlaç
Our Director of Biotechnology and New Product Assessment, Hasan Ersin Zeytin, MD, told TRT Haber about the vaccination activities carried out by Nobel İlaç.
Varank, Minister of Industry, Visited Our Biotechnological Pharmaceutical Plant in TÜBİTAK Marmara Teknokent
Visiting the Nobel İlaç Biotechnology Facility, Mustafa Varank, Minister of Industry and Technology, Mehmet Fatih Kaçır, Deputy Minister, Hasa...
Year-End Meeting of Nobel İlaç Has Started: We Are Connected To Each Other!
2020 has been an odd year for all of us. The epidemic has affected our lives and our ways of doing business, and continues to do so.
We Won Gold Award at Istanbul Marketing Awards 2020
Our “Masks That Make You Smile” Project that we have realized together with the Gülmek İyileştirir Association received the GOLD award in the Healthcare Communications / Customer-oriented category of...
Our Düzce Factory Receives TSE Covid-19 Safe Manufacturing Certificate
We qualified to receive TSE Covid-19 Safe Manufacturing Certificate on November 27th by fulfilling all the requirements of the Turkish Standards Institute's Covid-19 hygiene, infec...
1 Person Donates Blood 1000 People Gain Hope
There are thousands of hereditary blood disease and cancer patients in our country and these people constantly need blood transfusions. Decreased blood donations during the pandemic cause these patients who...
Nobel İlaç New R&D Center
Turkey, the largest pharmaceutical company engaged in pharmaceutical R&D investment Nobel, the new investment in R&D Center was completed in Düzce area.
Prestigious Award for Our Career Prescription Internship Program
We proudly completed the TOP100 Talent Program 2020 contest organized by the career platform of the best talents which is toptalent.co.
We are Reducing the Fever of the World
With the new communication concept of the Nobel İlaç Acute 1 Team brand which is "We are Reducing the Fever of the World", the Felis Awards Health Communication Department won the success award in the Launch / Re...
